These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 6490097

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Binding of C-reactive protein to human polymorphonuclear leukocytes: evidence for association of binding sites with Fc receptors.
    Müller H, Fehr J.
    J Immunol; 1986 Mar 15; 136(6):2202-7. PubMed ID: 3950412
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Leukocyte inhibitory factor (LIF) potentiates human macrophage aggregation and activation responses to calcium ionophore A23187 and directly induces leukotriene B4 and thromboxane A2 release.
    Conti P, Barbacane RC, Reale M, Panara MR, Placido FC, Mier JW, Castracane JM, Dempsey RA.
    Biotechnol Ther; 1993 Mar 15; 4(3-4):239-52. PubMed ID: 8292972
    [Abstract] [Full Text] [Related]

  • 9. Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia.
    Craddock PR, Hammerschmidt D, White JG, Dalmosso AP, Jacob HS.
    J Clin Invest; 1977 Jul 15; 60(1):260-4. PubMed ID: 874088
    [Abstract] [Full Text] [Related]

  • 10. Immunomodulators and the complement system.
    Kondo M, Kato H, Yoshikawa T, Sugino S.
    Methods Find Exp Clin Pharmacol; 1986 Feb 15; 8(2):67-72. PubMed ID: 3713376
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Interaction of human neutrophils and HL-60 cells with the extracellular matrix.
    Suchard SJ.
    Blood Cells; 1993 Feb 15; 19(2):197-221, discussion 221-3. PubMed ID: 7508769
    [Abstract] [Full Text] [Related]

  • 14. Signaling by hemolytically inactive C5b67, an agonist of polymorphonuclear leukocytes.
    Wang C, Gerard NP, Nicholson-Weller A.
    J Immunol; 1996 Jan 15; 156(2):786-92. PubMed ID: 8543834
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Chemotactic response of equine polymorphonuclear leucocytes to Streptococcus equi.
    Muhktar MM, Timoney JF.
    Res Vet Sci; 1988 Sep 15; 45(2):225-9. PubMed ID: 3194592
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Acute inflammation in peritoneal dialysis: experimental studies in rats. Characterization of regulatory mechanisms.
    Bazargani F.
    Swed Dent J Suppl; 2005 Sep 15; (171):1-57, i. PubMed ID: 15847249
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Plasma activity inducing polymorphonuclear neutrophils (PMN) aggregation, chemotactic plasma activity, and plasma activity augmenting PMN adherence in untreated patients with Hodgkin's disease. Possible relationship to disseminated intravascular complement activation.
    Wierusz-Wysocka B, Wysocki H.
    Oncology; 1984 Sep 15; 41(6):409-13. PubMed ID: 6504496
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.